World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
137
Citations
77903
World Ranking
59
National Ranking
29

Medicine

D-Index
138
Citations
78770
World Ranking
1819
National Ranking
1038

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2025 - Research.com Microbiology in United States Leader Award
  • 2017 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Member of the European Academy of Sciences and Arts

Overview

Dimitrios P. Kontoyiannis is a researcher affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their academic work primarily focuses on medicine, with extensive contributions in epidemiology, infectious diseases, oncology, pulmonary and respiratory medicine, and immunology. The research spans various aspects of fungal infections, antifungal resistance, and cancer-related infectious complications.

The scientist has published significant research on topics such as:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Neutropenia and cancer infections
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Nail diseases and treatments
  • Infectious diseases and mycology
  • Plant pathogens and fungal diseases

Their frequently published venues include:

  • Open Forum Infectious Diseases
  • Journal of Fungi
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • mBio

Dimitrios P. Kontoyiannis has collaborated extensively with co-authors such as Sebastian Wurster, Nathaniel D. Albert, Takahiro Matsuo, Ying Jiang, and Russell E. Lewis.

Notable recent publications include:

  • When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis, 2021, Journal of Fungi
  • Epidemiology and Organ Specific Sequelae of Post-Acute COVID-19: A Narrative Review, 2021, Journal of Infection
  • Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium, 2020, The Journal of Infectious Diseases
  • Impact of Climate Change and Natural Disasters on Fungal Infections, 2024, The Lancet Microbe
  • Environmental Candida auris and the Global Warming Emergence Hypothesis, 2021, mBio

Their work lies at the intersection of clinical infectious diseases and mycology, with significant attention to the effects of environmental factors and underlying conditions on fungal infections.

Dimitrios P. Kontoyiannis is recognized as a Fellow of the American Association for the Advancement of Science (AAAS) since 2017 and also holds fellowships and memberships in European scientific organizations, including the European Confederation of Medical Mycology and the European Academy of Sciences and Arts.

Best Publications

  • Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht

  • Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases

    Maureen M. Roden;Theoklis E. Zaoutis;Wendy L. Buchanan;Tena A. Knudsen

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

    Dimitrios P. Kontoyiennis;Kieren A. Marr;Benjamin J. Park;Barbara D. Alexander

  • Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

    Peter G. Pappas;Barbara D. Alexander;David R. Andes;Susan Hadley

  • Epidemiology and Clinical Manifestations of Mucormycosis

    George Petrikkos;Anna Skiada;Olivier Lortholary;Emmanuel Roilides

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

    Georgios Chamilos;Russell E. Lewis;Russell E. Lewis;Dimitrios P. Kontoyiannis

  • Pathogenesis of Mucormycosis

    Ashraf S. Ibrahim;Brad Spellberg;Thomas J. Walsh;Dimitrios P. Kontoyiannis

  • Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus-Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases

    Dimitrios P Kontoyiannis;Michail S. Lionakis;Russell E. Lewis;Russell E. Lewis;Georgios Chamilos

  • Glucocorticoids and invasive fungal infections.

    Michail S Lionakis;Dimitrios P Kontoyiannis

  • Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases

    Jo Anne H. van Burik;Roberta S. Hare;Howard F. Solomon;Michael L. Corrado

  • Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).

    Georgios Chamilos;Mario Luna;Russell E. Lewis;Russell E. Lewis;Gerald P. Bodey

  • Zygomycosis in the 1990s in a Tertiary-Care Cancer Center

    Dimitrios P. Kontoyiannis;Verena C. Wessel;Gerald P. Bodey;Kenneth V. I. Rolston

  • Recent Advances in the Management of Mucormycosis: From Bench to Bedside

    Brad Spellberg;Thomas J. Walsh;Dimitrios P. Kontoyiannis;J. John Edwards

  • Antifungal drug resistance of pathogenic fungi

    Dimitrios P Kontoyiannis;Russell E Lewis

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • Combination antifungal therapy for invasive aspergillosis a randomized trial

    Kieren A. Marr;Haran T. Schlamm;Raoul Herbrecht;Scott T. Rottinghaus

  • Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

    J. Morgan;K. A. Wannemuehler;K. A. Marr;S. Hadley

Frequent Co-Authors

Russell E. Lewis
Russell E. Lewis University of Padua
Issam I Raad
Issam I Raad The University of Texas MD Anderson Cancer Center
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Jeffrey J Tarrand
Jeffrey J Tarrand The University of Texas MD Anderson Cancer Center
Georgios Chamilos
Georgios Chamilos University of Crete
Ray Y Hachem
Ray Y Hachem The University of Texas MD Anderson Cancer Center
Emmanuel Roilides
Emmanuel Roilides Aristotle University of Thessaloniki
Michail S. Lionakis
Michail S. Lionakis National Institute of Allergy and Infectious Diseases
Kenneth V. I. Rolston
Kenneth V. I. Rolston The University of Texas MD Anderson Cancer Center
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of interdisciplinary career paths, particularly within the healthcare and information management sectors. For those interested in healthcare administration, pursuing a health information management degree salary can be a lucrative option, offering roles that blend biology knowledge with data and administrative skills.

Prospective students can find reputable programs through a cahiim accredited him degree online, ensuring their education meets industry standards and prepares them for certification.

Another promising avenue is healthcare coding and billing, where professionals manage patient data and billing processes. Certifications such as certified professional coder (cpc) help individuals validate their expertise and enhance job prospects. Additionally, accelerated training options like the medical billing and coding certificate online accelerated programs allow for quicker entry into the workforce.

Overall, microbiology graduates equipped with complementary skills in health information and coding are well-positioned to thrive in today's evolving healthcare landscape.

Best Scientists Citing Dimitrios P. Kontoyiannis

Trending Scientists

Recently Published Articles